An enzyme-induced conformational change is now implicated in activating the p53 protein, one of a cell's prime movers in preventing tumour development.
References
Zheng, H. et al. Nature 419, 849–853 (2002); advance online publication, 2 October 2002 (doi:10.1038/nature01116).
Zacchi, P. et al. Nature 419, 853–857 (2002); advance online publication, 2 October 2002 (doi:10.1038/nature01120).
Ryan, K. M., Phillips, A. C. & Vousden, K. H. Curr. Opin. Cell Biol. 13, 332–337 (2001).
Vousden, K. H. & Lu, X. Nature Rev. Cancer 2, 594–604 (2002).
Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Nature 387, 299–303 (1997).
Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Nature 387, 296–299 (1997).
Shaw, P. E. EMBO Rep. 3, 521–526 (2002).
Lu, K. P., Hanes, S. D. & Hunter, T. Nature 380, 544–547 (1996).
Rippmann, J. F. et al. Cell Growth Differ. 11, 409–416 (2000).
Liou, Y. C. et al. Proc. Natl Acad. Sci. USA 99, 1335–1340 (2002).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ryan, K., Vousden, K. Pinning a change on p53. Nature 419, 795–797 (2002). https://doi.org/10.1038/419795a
Issue Date:
DOI: https://doi.org/10.1038/419795a
- Springer Nature Limited
This article is cited by
-
Tau protein binds to the P53 E3 ubiquitin ligase MDM2
Scientific Reports (2023)
-
The complexity of p53 stabilization and activation
Cell Death & Differentiation (2006)
-
A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing
Nature Structural & Molecular Biology (2004)